Adaptive Biotechnologies Corporation (ADPT)
NASDAQ: ADPT · Real-Time Price · USD
13.69
+0.11 (0.81%)
Mar 23, 2026, 2:58 PM EDT - Market open
Adaptive Biotechnologies Market Cap
Adaptive Biotechnologies has a market cap or net worth of $2.11 billion as of March 23, 2026. Its market cap has increased by 82.59% in one year.
Market Cap
2.11B
Enterprise Value
2.07B
1-Year Change
82.59%
Ranking
Category
Stock Price
$13.69
Market Cap Chart
Since June 27, 2019, Adaptive Biotechnologies's market cap has decreased from $4.77B to $2.11B, a decrease of -55.85%. That is a compound annual growth rate of -11.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 2.09B | -15.66% |
| Dec 31, 2025 | 2.48B | 180.23% |
| Dec 31, 2024 | 884.74M | 24.72% |
| Dec 29, 2023 | 709.39M | -35.07% |
| Dec 30, 2022 | 1.09B | -72.41% |
| Dec 31, 2021 | 3.96B | -51.03% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jun 27, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Wave Life Sciences | 2.21B |
| Apellis Pharmaceuticals | 2.20B |
| Veradermics | 2.20B |
| Syndax Pharmaceuticals | 2.14B |
| Galapagos NV | 2.11B |
| Nektar Therapeutics | 2.07B |
| Celldex Therapeutics | 2.06B |
| Zai Lab | 2.00B |